Acs Research - Theorylab

Prostate cancer is the most common cancer among men (after skin cancer), and while it can often be treated successfully, metastatic disease remains challenging. Lloyd Trotman, PhD—a former American Cancer Society grantee and Professor at Cold Spring Harbor Laboratory—is trying to change that. He and his team recently developed the first genetic mouse model for the treatment and analysis of metastatic prostate cancer. Now they are seeking to translate their findings into patients to “turn lethal prostate cancer into a curable disease.”* In this interview he talks about the challenges of metastatic prostate cancer, the exciting discoveries he and his team have made, and how his work is getting closer to patients. *https://www.cshl.edu/research/faculty-staff/lloyd-trotman/